DBDarina T. Bassil

Darina T. Bassil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Darina T. Bassil has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Sarah Gao

    Center for Economic and Social Research, University of Southern California, Los Angeles, California, United States of America

    4 shared publications
  • Adam M. Brickman

    Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY USA

    3 shared publications
  • Jennifer J. Manly

    Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY USA

    3 shared publications
  • Lisa F. Berkman

    Harvard T.H. Chan School of Public Health, Cambridge, MA USA

    3 shared publications
  • Meagan T. Farrell

    Harvard T.H. Chan School of Public Health, Cambridge, MA USA

    3 shared publications
  • Stephen Tollman

    University of the Witwatersrand, Johannesburg South Africa

    3 shared publications

Latest Publications

  • Open Access

    Episodic memory trajectories of older adults with and without HIV: A longitudinal population-based study in rural South Africa

    by Michaela Theilmann, Sarah Gao, Darina T. Bassil, Ryan G. Wagner, Xuexin Yu, Eric Tchetgen Tchetgen, Molly Rosenberg, Carla Roberts-Toler, Brendan Maughan-Brown, Lindsay Kobayashi, et al.

    With the introduction of antiretroviral treatment (ART), life expectancy among people with HIV in South Africa has increased substantially. This ageing population faces age-related challenges, including cognitive decline. Yet, differences in cognitive trends between people with and without HIV remain poorly understood. We analyzed longitudinal data on 3,066 adults aged 40 + years in rural South Africa from the “Health and Aging in Africa: Longitudinal Studies in South Africa" (HAALSA) cohort. Using generalized estimating equations, we compared episodic memory trajectories over seven years (2014 – 2022) across three groups: (1) people without HIV, (2) people with HIV and suppressed viral load, and (3) people with HIV and unsuppressed viral load. Furthermore, we predicted episodic memory scores at yearly intervals. On average, the trend in episodic memory decline did not differ between people without HIV and people with HIV with suppressed or unsuppressed viral load. However, looking individually at yearly intervals revealed that participants without HIV experienced significantly steeper episodic memory decline compared to participants with HIV with suppressed viral load when controlling for individual-level characteristics. Consequently, over the seven-year period, participants without HIV progressed from having episodic memory comparable to those with suppressed viral load to levels similar to those with unsuppressed viral load. The slower episodic memory decline among virally suppressed people with HIV compared to those without HIV may reflect benefits from regular healthcare engagement or may also be a result of selective mortality. Our findings suggest that policymakers should: (1) intensify efforts to increase ART coverage and adherence among unsuppressed people with HIV; (2) implement targeted cognitive screening for at-risk individuals regardless of HIV status; (3) expand screening and treatment for conditions that contribute to cognitive decline; and (4) promote behaviors that may preserve cognitive function, particularly in resource-constrained settings. Further research on potential underlying mechanisms should be conducted.

  • Open Access

    Exploring the relationship between pain, cognition, and chronic conditions: insights from the HAALSI study in rural South Africa

    by Camryn Dixon, Tamara P Taporoski, F Xavier Gomez-Olive Casas, Stephen M Tollman, Lisa F Berkman, Darina T Bassil

    Background: Research on cognition and pain is limited in Low and Middle-income Countries (LMICs) and understanding how chronic conditions and pain treatment may moderate this association is underexplored. This study aimed to explore the relationship between pain and cognition and the moderating effect of hypertension, diabetes, HIV, pain treatment, and depressive symptoms. Methods: We analyzed data from 3803 individuals enrolled in the HAALSI study, a longitudinal population study of older adults in Agincourt, South Africa. Pain was measured with the Brief Pain Inventory. Cognition was assessed using a composite of orientation questions, a memory test, and the Trails Making Test B. Chronic conditions were assessed using biological measures, and depressive symptoms were measured using the CES-D scale. Linear regression models were used to investigate the relationship. Results: Baseline and longitudinal pain were significantly associated with poorer episodic memory (ß = −0.17 [P < .001]; ß = −0.18 [P < .001]). Hypertension amplified the negative effect of pain on episodic memory, while diabetes and HIV did not moderate the relationship between pain and cognition (ß = −0.10 [.006]). Pain treatment was associated with poorer cognitive performance. Depressive symptoms moderated the relationship between pain and both cognition and executive function (EF) (P = .02). The negative effect of pain on episodic memory was observed in individuals with both acute and persisting pain, while it only affected EF in those with acute pain. Conclusions: These findings highlight the importance of examining factors that may moderate the relationship between pain and cognition and strategies to mitigate the effect pain has on cognition, particularly in LMICs.


  • Open Access

    Assessing the feasibility of dried blood spot (DBS) collection for blood‐based biomarkers of Alzheimer’s Disease in rural South Africa

    by Sarah Gao, Darina T. Bassil, Ryan G. Wagner, Jacques du Toit, Hanna Huber, Nicholas J. Ashton, Dejania Cotton‐Samuel, Meagan T. Farrell, Victor Mngomezulu, Jennifer J. Manly, et al.

    Background: The characterization of Alzheimer’s disease (AD) and AD related dementias (ADRD) pathophysiology has been revolutionized by the development of highly sensitive blood‐based biomarkers. Although blood‐based biomarkers allow for greater access, cost effectiveness, and scalability, there are limitations for their implementation in resource‐constrained low‐ and middle‐income countries (LMICs) and rural settings, where access to equipment, freezers, and assays is often limited. Dried blood spot (DBS) collection emerges as a promising, convenient, and cost‐effective method for acquiring blood samples in these contexts, but it is unclear whether highly sensitive assays typically applied to cerebrospinal fluid (CSF), plasma, or serum can detect biomarker concentrations accurately. This pilot study assessed the feasibility of using DBS to measure blood‐based AD biomarkers by examining the agreement between ADRD biomarker concentrations derived from DBS and from plasma in older adults in rural South Africa.Method: Data were collected from the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI), an ongoing population cohort of 5,059 adults aged ≥40 years living in Agincourt, South Africa. This study focuses on a sub‐sample of 95 participants, whose venous blood and DBS were collected during the HAALSI visit and later tested for blood‐based ADRD biomarkers, including neurofilament light chain (NfL), phosphorylated‐tau181 (p‐tau181), and glial fibrillary acidic protein (GFAP). Plasma and DBS markers were analyzed using commercially available Single molecule array assays (Quanterix) at the University of Gothenburg. We ran pairwise correlations that examined the association between the plasma and DBS measures of p‐tau181, NfL, and GFAP.Result: The sample consisted of 70.5% women, with an average age of 67.53 years (SD=9.69). We observed a positive correlation between plasma and DBS GFAP concentrations (r=0.78, p‐value<0.001). However, DBS and plasma concentrations were not correlated for p‐tau181 (r=0.05, p‐value=0.62) or for NfL (r=‐0.04, p‐value=0.68).Conclusion: These preliminary analyses suggest that GFAP concentration, a marker of astrogliosis, can be measured consistently in DBS. These findings have important implications for the selection and analysis of AD blood‐based biomarkers in low‐resource and LMIC settings, where venous blood draws may not be feasible.


  • Open Access

    Measuring Visuospatial Ability in Low‐Literacy Older Adults: A Comparison of the Constructional Praxis and Stick Design Tests in Rural South Africa

    by Darina T. Bassil, Meagan T. Farrell, Muqi Guo, Sarah Gao, Nomsa Mahlalehla, Adam M. Brickman, Jennifer J. Manly, Lisa F. Berkman

    Background: Dementia criteria require not only memory impairment, but additional impairment in at least one other cognitive domain, like visuospatial functioning. Cognitive measures assessing visuospatial function often involve drawing shapes. While these measures have proven reliable and valid in developed countries, their use in Low and Middle‐income Countries (LMICs) is challenging due to cultural differences and low literacy. Cultural and educational bias in visuospatial tests prevents comprehensive assessment of neuropsychological function, thus limiting dementia assessment in LMICs. Here, we compare the Stick Design Test (SDT) to Constructional Praxis (CP) for assessing visuospatial functioning among older South Africans adults.Method: We used data from Cognition and Dementia in the Health and Aging in Africa: A Longitudinal Study in South Africa (HAALSI‐HCAP), a population‐based nested cohort study in rural Agincourt, South Africa. In 2022, 675 participants, aged ≥ 50, were administered the immediate and delayed recall trials of the SDT and CP, as part of HAALSI‐HCAP cognitive battery. CP, completed on a tablet, involved copying four geometric shapes, while SDT required participants to reconstruct four configurations using matchsticks. Scoring for both CP (0‐11) and SDT (0‐12) was subsequently completed by trained researchers. We assessed acceptability and performance of both measures across participant demographics and investigated their correlation with performance on other visuospatial measures to ascertain criterion validity.Result: Participants were mostly women (63%), without education (58%) with mean age of 72.5±11. Refusals and missingness were more common for CP (40%) than SDT (13%). SDT had a more normal distribution compared to CP, overall and for individual figures. Worse performance was associated with higher age and lack of formal education for both measures. However, SDT demonstrated less extreme z‐standardized scores, particularly among those without education and over 70 years old. Participants were more likely to recall SDT configurations than CP figures after a delay. SDT showed weak but significant correlations (p<0.001) with CP(r = 0.14), Raven’s Matrices(r = 0.27), and Symbol Cancellation (r = 0.38).Conclusion: SDT outperformed CP in acceptability and demonstrated lower sensitivity to education. Convergent validity findings suggest that SDT may be a robust and culturally adaptable measure for assessing visuospatial functioning in older populations, especially in low‐resource settings.

  • Open Access

    Exploring the relationship between neuropsychiatric symptoms, cognitive test performance, and brain abnormalities in a cohort of older adults in rural South Africa

    by Sarah Gao, Darina T. Bassil, Meagan T. Farrell, Ryan G. Wagner, Jennifer J. Manly, Adam M. Brickman, Stephen Tollman, Lisa F. Berkman

    Background: People with Alzheimer’s Disease (AD) often have neuropsychiatric symptoms. The Neuropsychiatric Inventory (NPI) is a validated tool for assessing the severity of these symptoms, but its applicability in a South African context remains unexamined. This study evaluated NPI‐Q, a brief version of the NPI, in relation to cognitive performance and markers of brain atrophy and emotional regulation among older South African adults.Method: Data were from Cognition and Dementia in the Health and Aging in Africa: A Longitudinal Study in South Africa (HAALSI‐HCAP), a population‐based nested cohort study in Agincourt, South Africa. The survey included a cognitive battery, clinical examination, and informant interview to assess perceived cognitive and functional changes in respondents. During the informant interview, the NPI‐Q was completed, and a severity score was derived from the cumulative sum of reported individual symptom scores (range: 0‐36). The final sample included 626 participants (71.9±11.3 years‐old, 35.6% men, 56.6% without formal education), of whom 185 underwent MRI scans. Pairwise correlations assessed the relationship between informant reported symptom severity with cognitive measures and MRI‐generated bilateral amygdala volume.Result: A total of 95 informants (15.2%) reported any neuropsychiatric symptoms, averaging 2.48 per participant among those who reported any symptom. Hallucinations were the most common symptom (5.4%), while disinhibition was the least (1%). Among those who reported symptoms, average symptom severity score was 4.28 (SD: 3.65). Severity was significantly correlated (p‐value<0.001) with most cognitive measures assessing general cognition (β: ‐0.27, ‐0.17), episodic memory (β: ‐0.26, ‐0.17), language (β: ‐0.28, ‐0.12), and executive function (β: ‐0.26, ‐0.12). However, no relationship was observed between neuropsychiatric symptoms and visuospatial functioning or amygdala volume, possibly attributable to high rate of missingness for visuospatial measures (30%), and the small MRI sample size reporting symptoms (n = 26).Conclusion: NPI‐Q symptoms were associated with lower cognitive performance, revealing a significant relationship between symptom severity and cognitive performance across all measures of the HAALSI‐HCAP cognitive battery, except for those evaluating visuospatial function. Associations between neuropsychiatric symptoms and bilateral amygdala volume were less evident. These results contribute to understanding the impact of neuropsychiatric symptoms on cognitive health in aging South African populations.

  • Open Access

    Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa

    by Meagan T Farrell, Darina T Bassil, Muqi Guo, M Maria Glymour, Ryan G Wagner, Stephen Tollman, Kenneth M Langa, Adam M Brickman, Jennifer J Manly, Lisa F Berkman